Manufacturer of Controlled Substances; Notice of Application, 22146 [2011-9610]
Download as PDF
<![CDATA[
22146
Federal Register / Vol. 76, No. 76 / Wednesday, April 20, 2011 / Notices
named as respondents Astra Tobacco
Corporation of Chapel Hill, North
Carolina; delfortgroup AG of Traun,
Austria; LIPtec GmbH and Julius Glatz
GmbH of Neidenfels, Germany.
On March 22, 2011, the ALJ issued an
ID (Order No. 5) granting complainant
Schweitzer’s motion to amend the
complaint and notice of the
investigation to add seven additional
respondents to the investigation. The
new respondents are Dosal Tobacco
Corp.; Farmer’s Tobacco Co.; S&M
Brands, Inc.; Tantus Tobacco, LLC;
KneX Worldwide, LLC; Dr. Franz
Feurstein GmbH; and
PapierfabrikWattens GmbH & Co. KG.
No party petitioned for review of the
subject ID. The Commission has
determined not to review the ID.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in
section 210.42(h) of the Commission’s
Rules of Practice and Procedure (19 CFR
210.42(h)).
By order of the Commission:
Issued: April 18, 2011.
William R. Bishop,
Hearings and Meetings Coordinator.
By order of the Commission.
Issued: April 15, 2011.
James R. Holbein,
Acting Secretary to the Commission.
Cocaine (9041) ..............................
Ecgonine (9180) ............................
[FR Doc. 2011–9584 Filed 4–19–11; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[USITC SE–11–010]
Government in the Sunshine Act
Meeting Notice
United
States International Trade Commission.
TIME AND DATE: April 28, 2011 at 11 a.m.
PLACE: Room 110, 500 E Street SW.,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
1. Agendas for future meetings: none.
2. Minutes.
3. Ratification List.
4. Vote in Inv. Nos. 701–TA–475 and
731–TA–1177 (Final) (Aluminum
Extrusions from China). The
Commission is currently scheduled to
transmit its determinations and
Commissioners’ opinions to the
Secretary of Commerce on or before May
13, 2011.
5. Outstanding action jackets: none.
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting. Earlier Notification
of this meeting was not possible.
srobinson on DSKHWCL6B1PROD with NOTICES
AGENCY HOLDING THE MEETING:
VerDate Mar<15>2010
17:52 Apr 19, 2011
Jkt 223001
Drug Enforcement Administration
(DEA) as a bulk manufacturer of the
following basic classes of controlled
substances:
[FR Doc. 2011–9726 Filed 4–18–11; 4:15 pm]
Drug
BILLING CODE 7020–02–P
Amphetamine (1100) ....................
Phenylacetone (8501) ..................
Schedule
II
II
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on February 24, 2011,
Stepan Company, Natural Products
Dept., 100 W. Hunter Avenue,
Maywood, New Jersey 07607, made
application by renewal to the Drug
Enforcement Administration (DEA) as a
bulk manufacturer of the following basic
classes of controlled substances:
Drug
Schedule
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than June 20, 2011.
Dated: April 13, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than June 20, 2011.
Dated: April 13, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–9610 Filed 4–19–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated June 17, 2010, and
published in the Federal Register on
June 28, 2010, 75 FR 36679, Lin Zhi
International Inc., 670 Almanor Avenue,
Sunnyvale, California 94085, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in schedules I and II:
[FR Doc. 2011–9619 Filed 4–19–11; 8:45 am]
Drug
Schedule
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on November 3, 2010,
Noramco Inc., 500 Swedes Landing
Road, Wilmington, Delaware 19801–
4485, made application by letter to the
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Tetrahydrocannabinols (7370) .....
3,4Methylenedioxymethamphetamine (MDMA) (7405).
Cocaine (9041) .............................
Oxycodone (9143) ........................
Hydrocodone (9193) .....................
Methadone (9250) ........................
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
I
I
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances as bulk
reagents for use in drug abuse testing.
E:\FR\FM\20APN1.SGM
20APN1
]]>Agencies
[Federal Register Volume 76, Number 76 (Wednesday, April 20, 2011)]
[Notices]
[Page 22146]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-9610]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on November 3, 2010, Noramco
Inc., 500 Swedes Landing Road, Wilmington, Delaware 19801-4485, made
application by letter to the Drug Enforcement Administration (DEA) as a
bulk manufacturer of the following basic classes of controlled
substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Amphetamine (1100)......................... II
Phenylacetone (8501)....................... II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than June 20, 2011.
Dated: April 13, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-9610 Filed 4-19-11; 8:45 am]
BILLING CODE 4410-09-P
